Jump to content

Immune system

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by ColForbin (talk | contribs) at 23:41, 19 August 2006 (revert misspelling). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

You must add a |reason= parameter to this Cleanup template – replace it with {{Cleanup|July 2006|reason=<Fill reason here>}}, or remove the Cleanup template.

The Immune System (also known as the Immunological System) and the Lymphatic System is made up of all the mechanisms through which a multicellular organism defends itself from internal invaders such as bacteria, viruses or parasites.

The immune system can be divided into two main branches:

This division is useful for categorizing the different components of the immune system, but it is important to recognize that in the immune response there is continuous interplay between members of both branches.

Innate Non-specific Mechanisms

The innate system is comprised of all the mechanisms that defend an organism in non-specific form, against an invader, pathogen, responding in the same fashion, regardless of what it is. It constitutes older defense strategies, some of these being found in primitive multicellular forms, in plant and fungi.

Physical Barriers

  • The skin is the first and main line of defense. The surface is made up of dead skin cells rich in keratin, which impedes microorganisms from entering the body. Lightly acidic and lipidic secretions from sebaceous gland and sweat glands create a hostile cutaneous environment impeding the excessive growth of bacteria.
  • Gastric acid is a powerful defense against invading bacteria from the intestines. Few species are able to survive the low pH and destructive enzymes that exist in the stomach.
  • Saliva and tears contain antibacterial enzymes, such as Lysozyme, which destroy the cellular walls of bacteria.
  • In the intestines, the bacterial flora compete with one another and non-commensal pathogens for food and space, diminishing the probability of pathogenic bacteria multiplying in sufficient numbers to cause illness. For this reason the excessive ingestion of oral antibiotics can lead to the depletion of benign bacteria in the intestine. Upon ending treatment, dangerous species can multiply without any competition, thereby causing many illnesses.
  • Mucus is another defense, coating the mucous membranes. It catches and immobilizes invading bodies, its composition is deadly to many microorganisms. It also contains Type IgA antibodies (which are a component of the adaptive immune system).

Phagocytes

See also Phagocyte

Phagocytes are cells, such as neutrophils, monocytes and macrophages, that have the capacity to directionally extend cellular portions of their plasma membrane (pseudopods), engulfing and overtaking a foreign particle or microorganism. The invading microorganism is contained inside a vacuole which merges with lysosomes, vacuoles rich in enzymes and acids, which digest the particle or organism. Phagocytes react to highly specialized molecular signals (cytokines) produced by T-cells (lymphocytes), but also patrol the body autonomously, albeit in a less efficient manner. This form of defense is important against bacterial infections, as viruses typically have their own means of entering host cells and the majority of parasites are too large to be consumed. Phagocytosis is also an important part of the cleaning process after cellular destruction following infection, tissue trauma, exposure to toxins, or any other process that leads to cellular death. Should many phagocytes die after phagocytosis, both phagocytes and bacteria can be trapped in a pasty liquid rich in stuctural proteins, known as pus.

Some bacteria, such as Mycobacterium tuberculosis, which causes tuberculosis, have defense mechanisms against digestion after phagocytosis, and survive within the phagocyte undetectable by lymphocytes.

Phagocytes and related cells:

  • Neutrophils: the most abundant type of phagocyte, normally 70% - 80% of WBCs, and is usually the first to arrive at the scene of infection. Along with its lysosomal enzymes, it destroys foreign substances or kills pathogens with its "respiratory burst." The neutrophil respiratory burst is a chain of reactions that produces hydrogen peroxide, which almost immediately releases its oxygen ion to form hypochlorite by combining with surrounding chloride ions. Hydrogen peroxide, with its release of oxygen ion, and hypochlorite, are strong oxidizing agents which accomplish destruction of foreign substances and pathogens. For this respiratory burst, the neutrophil increases its oxygen uptake a hundred fold. Niacin in the form of NADPH is essential in speeding up the reaction time.
  • Macrophages: a gigantic cell, or "freed" monocyte, has the capacity to consume many more bacteria than a neutrophil. Monocytes are large phagocytic white blood cells (WBCs), that have the ability to travel out of the circulatory system by moving across the cell membrane of capillary vessels and entering the interstitial fluid in pursuit of invading pathogens. Once the monocyte leaves the circulatory system, it is properly termed a macrophage, meaning "large eating cell". Its arrival at a potential infection site is the result of the release of cytokines. It is more efficient in destroying bacteria than neutrophils, but lives for a shorter amount of time, having to be replaced by additional monocytes during each infection. It has its own respiratory burst, releasing nitric oxide from arginine. Nitric oxide and chemicals that arise from it, particularly peroxynitrite, can kill viruses, bacteria, fungi, protozoa, some helminths, and tumor cells.
  • Basophils and Mast Cells: While they possess very little phagocytic activity, these cells release histamine and are important in allergic reactions (such as asthma) and also defending against parasites. They are activated by binding the antibody type IgE.
  • Eosinophils: a non-consuming cell related to the neutrophil. An important part of defense against parasites.

Neutrophils, eosinophils and basophils are also known as polymorphonuclear leukocytes (due to their lobed nuclei) or granulocytes.

Natural Killer Cells

See also Natural killer cell

Natural killer cells or (NK) cells are a major component of the innate immune system, and are distinctive in that NK cells are lymphocytes that attack cells that have been infected by microbes, but not microbes themselves. NK cells also display activity against some tumor cells. They were named "natural killer" because of the initial notion that they do not require activation in order to kill cells which are "missing self." "Missing-self" is a term used to describe cells with low levels of MHC (major histocompatibility complex) class I cell surface marker molecules—a situation which can arise due to viral infection, or in tumors under strong selection pressure of killer T cells.

Complement System

See also Complement system

The complement system is a biochemical cascade of the immune system that helps clear pathogens from an organism. It is derived from many small plasma proteins working together to form the primary end result of cytolysis by disrupting the target cell's plasma membrane. The proteins are sythesized in the liver, mainly by hepatocytes.

Other non-specific proteins include Protease C3-convertase, which is also sythesized in the liver and connects to other molecules that are commonly found in bacteria but non-existent in humans, stimulating the complement system and phagocytosis.

Inflammation

See also Inflammation

Inflammation is the first response of the immune system to infection or irritation and may be referred to as the innate cascade. Inflammation is characterised by the following quintet: redness (rubor), heat (calor), swelling (tumor), pain (dolor) and dysfunction of the organs involved (functio laesa). The first four characteristics have been known since ancient times and are attributed to Celsus; functio laesa was added to the definition of inflammation by Rudolf Virchow in 1858.

Inflammation is stimulated by chemical factors released by injured cells. These factors (histamine, bradicine) sensitize pain receptors and cause vasodilation of the blood vessels at the scene (rubor, calor and tumor), and also attract phagocytes, especially neutrophils. Phagocytosis causes the neutrophils to release other factors that call lymphocytes and other phagocytes.

Specific or Adaptive Immune System

The basis of specific immunity lies in the capacity of immune cells to distinguish between proteins produced by the body's own cells ("self" antigen - those of the original organism), and proteins produced by invaders or cells under control of a virus ("non-self" antigen - or, what is not recognized as the original organism). This distinction is made via T-Cell Receptors (TCR) or B-Cell Receptors (BCR). For these receptors to be efficient they must be produced in thousands of configurations, this way they are able to distinguish between many different invader proteins. This immense diversity of receptors would not fit in the genome of a cell, and millions of genes, one for each type of possible receptor, would be impractical. What happens is that there are a few families of genes, each one having a slightly different modification. Through a special process, unique to cells of jawed vertebrates (Gnathostomata), the genes in these lymphocytes recombine, one from each family, arbitrarily into a single gene.

This way, for example, each antibody or BCR of B lymphocytes has six portions, and is created from two genes unique to this lymphocyte, created by the recombiation (union) of a random gene from each family. If there are 6 families, with 50, 30, 9, 40, and 5 members, the total possible number of antibodies is 50x30x6x9x40x5 = 16 million. On top of this there are other complex processes that increase the diversity of BCR or TCR even more, by mutation of the genes in question. The variability of antibodies is practically limitless, and the immune system creates antibodies for any molecule, even artificial molecules that do not exist in nature.

Many TCR and BCR created this way will react with their own peptides. One of the functions of the thymus and bone marrow is to hold young lymphocytes until it is possible to determine which ones react to molecules of the organism itself. This is done by specialized cells in these organs that present the young lymphocytes with molecules produced by them (and effectively the body). All the lymphocytes that react to them are destroyed, and only those that show themselves to be indifferent to the body are released into the bloodstream.

The lymphocytes that do not react to the body number in the millions, each with millions of possible configurations of receptors, each with a receptor for different parts of each microbial protein possible. The vast majority of lymphocytes never find a protein that its receptor is specified for, those few that do find one are stimulated to reproduce. Effective cells are generated with the specific receptor and memory cells. These memory cells are quiescent, they have long lives and are capable of identifying this antigen some time later, multiplying themselves quickly and rapidly responding to future infections.

The specific immune system is controlled directed largely by lymphocytes. There are various types of lymphocytes:

B Lymphocytes and Antibody Production

see B cells

B cells are lymphocytes that play a large role in the humoral immune response (as opposed to the cell-mediated immune response). The abbreviation "B" stands for the bursa of Fabricius which is an organ unique to birds, where avian B cells mature. It does not stand for bone marrow, where B cells are produced in all other vertebrates except for rabbits (where B cells develop in the appendix-sacculus rotundus). B cells were initially observed in studies done on immunity in chickens, and similar cells were subsequently discovered in humans. The designation B cell was retained in human lymphocytes.

The human body has the ability to form millions of different types of B cells each day, and each type has a unique receptor protein (referred to as the B cell receptor (BCR)) on its membrane that will bind to one particular antigen. At any one time in the human body there are B cells are circulating in the blood and lymph, but are not producing antibodies. Once a B cell encounters its cognate antigen and receives an additional signal from a helper T cell, it can further differentiate into one of the two types of B cells listed below. The B cell can either directly become one of these cell types or go through an intermediate differentiation step - the germinal center reaction where the B cell will hypermutate the variable region of the antibody and possibly class switch.

Plasma cells secrete antibodies which assist in the destruction of antigens by binding to them and making them easier targets for phagocytes (a process known as opsonization). Antibodies can also elicit the complement cascade, which also makes antigens an easier target for other cells.

Memory cells are formed specific to the antigen(s) encountered during the primary immune response; able to live for a long time, these cells can respond quickly upon second exposure to the antigen for which they are specific. Humoral immunity (the creation of antibodies that circulate in blood plasma and lymph) involves B cell activation. Cell activation can be gauged using the ELISPOT technique, which can determine the percentage of B cells that secrete any particular antibody.

B cells are characterised immunohistochemically in humans by the presence of CD20 on the cell membrane. In mice, CD45 (B220) is often used.

A critical difference between B cells and T cells is how each cell "sees" an antigen. B cells recognize their cognate antigen in its native form. In contrast, T cells recognize their cognate antigen in a processed form - as a peptide in the context of an MHC molecule.

Susumu Tonegawa won the 1987 Nobel Prize in Physiology or Medicine for demonstrating how B cells create the enormous diversity of antibodies from only a few genes. The Nobel presentation [1] gives an overview.

Production of B cells B cells are produced through several stages, each stage represents a change in the genome content, in which the variety of antibodies are produced. The human antibody is composed of two light and two heavy chains, and there are genes specifying them, which is known as the 'H' chain loci and the 'L' chain loci. In the H chain loci there are three regions, V, D and J, and combinations of threes are drawn, in terms of rearrangement which results in deletions of bases between the two selected points, and results in formation of a unique combination. In the L chain loci there are only two regions, namely V and J, which undergoes the same process.

Progenitor B cells - Contains Germline H genes, Germline L genes Early Pro-B cells - undergoes D-J rearrangement on the H chains Late Pro-B cells - undergoes V-DJ rearrangement on the H chains Large Pre-B cells - the H chain is VDJ rearranged, Germline L genes Small Pre-B cells - undergoes V-J rearrangement on the L chains Immature B cells - VJ rearranged on L chains, VDJ rearranged on H chains. There is start of expression of IgM receptors. Mature B cells - There is start of expression of IgD When the B cells fails in any step of the maturation process, it will undergo apoptosis, and if it recognizes self-antigen during the maturation process, it will become suppressed (known as anergy) or undergo apoptosis.

B cells are continuously produced in the bone marrow, but only a small portion of newly made B cells survive to participate a part in the long-lived peripheral B cell pool.

CD8+ T Lymphocytes and Cytotoxicity

see Cytotoxic T cells Cytotoxic T cell

A cytotoxic T cell (also known as TC or killer T cell) is a sub-group of T lymphocyte (a type of white blood cell) which is capable of inducing the death of infected somatic or tumor cells; they kill cells that are infected with viruses (or other pathogens), or are otherwise damaged or dysfunctional.

Most cytotoxic T cells express T-cell receptors (TcRs) that can recognise a specific peptide antigen bound to Class I MHC molecules. These TC cells also express CD8, which is attracted to portions of the Class I MHC molecule. This affinity keeps the TC cell and the target cell bound closely together during antigen-specific activation. TC cells with CD8 surface protein are called CD8+ T cells, and CD8+ T cells are generally classified as having a pre-defined cytotoxic role within the immune system.

Contents [hide] 1 Cytotoxic T cell development 2 Cytotoxic T cell activation 3 Cytotoxic T cell role in disease pathogenesis 4 References


Cytotoxic T cell development

Hematopoetic stem cells in the bone marrow migrate into the thymus, where they undergo VDJ rearrangement of their beta-chain TcR DNA to form a developmental form of the TcR protein, known as pre-TcR. If that rearrangement is successful, the cells then rearrange their alpha-chain TcR DNA to create a functional alpha-beta TcR complex. This highly-variable genetic rearrangement product in the TcR genes helps create millions of different T cells with different TcRs, helping the body's immune system respond to virtually any protein invader. The vast majority of T cells express alpha-beta TcRs, but some T cells in epithelial express beta-gamma TcRs, which recognize non-protein antigens.

T cells with functionally stable TcRs express both the CD4 and CD8 co-receptors and are therefore termed "double-positive" T cells (CD4+/CD8+). The double-positive T cells are exposed to a wide variety of self-antigens in the thymus and undergo two selection criteria: (1) negative selection, in which those double-positive T cells that bind too strongly to MHC-presented self antigens undergo apoptosis because their propensity to become autoreactive could lead to autoimmunity; and (2) positive selection, in which those double-positive T cells that bind too weakly to MHC-presented self antigens undergo apoptosis because of their inability to recognize MHC-protein complexes. Only those T cells that bind to the MHC-self-antigen complexes weakly are positively selected. Those cells that survive positive and negative selection differentiate into single-positive T cells (either CD4+ or CD8+).

Cytotoxic T cell activation

With the exception of some cell types such as non-nucleated cells (including erythrocytes), Class I MHC is expressed by all host cells. When these cells are infected with a virus (or another intracellular pathogen), the cells "break down" foreign proteins via antigen processing. These result in peptide fragments, some of which can bind to MHC Class I and become antigenic to CD8+ T cells.

Cytotoxic T cells are activated when their TcR strongly interacts with a peptide-bound MHC class I molecule. Once activated they undergo clonal expansion (with the help of Interleukin-2 provided by helper T cells. They then travel throughout the body in search of antigen-positive somatic cells.

When exposed to infected/dysfunctional somatic cells, TC cells release the cytotoxins perforin and granulysin, which forms pores in the target cell's plasma membrane; this causes ions and water to flow into the target cell, making it expand and eventually lyse. TC also release granzyme, a serine protease, that can enter target cells via the perforin-formed pore and induce apoptosis (cell death).

A second way to induce apoptosis is via cell-surface interactions between the TC and the infected cell. When a TC is activated it starts to express the surface cytokine FAS ligand, which can bind to Fas molecules on the target cell. This Fas-Fas ligand interaction is the main route to dispose of unwanted T lymphocytes during their development.

Cytotoxic T cell role in disease pathogenesis

Hepatitis B virus (HBV) infection

During HBV infection cytotoxic T cells play an important pathogenetic role. They contribute to nearly all of the liver injury associated with HBV infection and, by killing infected cells and by producing antiviral cytokines capable of purging HBV from viable hepatocytes, cytotoxic T cells also eliminate the virus. Recently platelets have been shown to facilitate the accumulation of virus-specific cytotoxic T cells into the infected liver.

Phagocytes

Though phagocytes are an innate mechanism, since they respond to any foreign body, they are also the first line decision makers for lymphocytes.

Phagocytes, especially macrophages, respond to cytokines generated by lymphocytes. Monocytes are the precursors to macrophages and they transform into macrophages when stimulated by CD4+ T cytokines. They are also attracted by other cytokines and factors emitted by cells in areas of active infection.

If properly stimulated by cytokines emitted in a localized and controlled manner by CD4+ T lymphocytes, the macrophages release sufficient quantities of enzymes and free radicals to completely destroy a localized area, killing both invaders and human cells.

On top of this, under control of lymphocytes, macrophages are responsible for some specific immunological reactions such as granuloma and abscesses. Granuloma occurs during an invasion of microbacteria and fungi, the most well-known example being tuberculosis. It is a reaction commanded by cytokines fro CD4+ T cells, when there is intracellular infection of the phagocytes themselves. In order to stop the invader from entering the bloodstream and spreading throughout the body in these mobile cells, the CD4+ lymphocytes secrete cytokines that call more macrophages, and make them more resistant to infection. Cytokines also provoke an adaptation in macrophages of epithelial morphology around the area of invasion, with numerous layers of immobilized cells connected by water-resistant links as to close off the invader. The tuberculosis microbacteria cannot propagate and remains stagnant. Today hundreds of millions of healthy people have microbacteria controlled in this form within their lungs (visible in x-rays). Only in those that have severely debilitated immunities do these pathogens escape and cause tuberculosis. The abscess is similar, surrounded by a cyst of pus. It is important to sequester pathogenic bacteria whose toxicity kills phagocytes (forming the pus) and does not permit efficient cleaning.

CD4+ Lymphocytes and Response Supervision

CD4+ Lymphocytes, or helper T cells, are immune response controllers. They "decide" which actions to take during an invasion, promoting or inhibiting all other immune cells via cytokines. HIV, being a virus that directly attacks the CD4+ T cells, causes a collapse of the entire system by attacking the root.

CD4+ lymphocytes are able to decide of there is an invasion due to the fact that each cell contains a randomly created TCR. All phagocytes and some other cells, such as dendrites, after digesting the proteins of an invader retain some of the peptides in a protein membrane, MHC. The TCR of the CD4+ T lymphocytes attach to the MHC II via the peptide and if the connection is effective, liberates cytokines. Almost no CD4+ T lymphocytes contain TCRs that react against self peptides, these were destroyed during the cell development in the thymus. If the levels of these cytokines are sufficiently high, and if other, less known factors exist in the blood, the CD4+ T lymphocytes "decide" that there is an invasion and what sort, beginning the specific immune response. The CD4+ T lymphocytes then produce other cytokines activating other cells for the appropriate response. As with other lymphocytes, stimulated CD4+ T lymphocytes multiply and some serve as memory cells to speed up future responses.

There are essentially two types of CD4+ T helpers, corresponding to two types of responses. The TH1 response is characterized by the production of cytokines such as IL-2, IFN-gamma and TNF-beta. Macrophages are activated, and through cytotoxic mechanisms (T lymphocytes), the infected areas are extensively destroyed. It is efficient in elimination of intracellular pathogens (intracellular viruses and bacteria). In the TH2 response there is a release of IL-4 and IL-5. It is characterized by the production of antibodies from B lymphocytes. It is effective against organisms in the blood, such as extra-cellular bacteria and parasites.

Which response (TH1 or TH2) is produced is important to the progression of the infection. For example, in leprosy, an infection caused by the intracellular Mycobacterium leprae, the TH1 response is extremely effective and the infection is kept to minimum (lepra tuberculoide) ; but if a response TH2 is activated, ineffective against intracellular organisms, common leprosy occurs causing extensive damage and loosening of the skin (lepra lepromatosa).

There is a third type of T lymphocyte, the regulatory T cells (Treg), which limit and suppress the immune reaction against self-antigens, an important mechanism considering the extreme destruction the immune system can cause.

Disorders of the human immune system

The most important function of the human immune system occurs at the cellular level of the blood and tissues. The lymphatic and blood circulation systems are paths for specialized white blood cells to travel around the body. White blood cells include B cells, T cells, natural killer cells, macrophages, and dendritic cells. Each has a different responsibility, but all function together with the primary objective of recognizing, attacking and destroying bacteria, viruses, cancer cells, and all other pathogens. Without this coordinated effort, a person would not be able to survive more than a few days before succumbing to an overwhelming infection. When a pathogen has entered the body, it sets off a chain reaction that starts with the activation of macrophages and natural killer cells that reach the site of infection and destroy as much of the pathogen as possible. While this is happening, it is the job of the dendritic cells to take “snap-shots” of the battle-ground to take to the lymph nodes in order to activate T cells which then activate B cells to produce antibodies against the pathogen.

Many disorders of the human immune system fall into two broad categories that are characterized by:

Other factors that affect immune response

Many factors can also contribute to the general weakening of the immune system:

Pharmacology

Despite high hopes, there are no medications that directly increase the activity of the immune system. Various forms of medication that activate the immune system may cause autoimmune disorders. Adjuvants (often Aluminium Hydroxide) can be used in conjunction with a vaccine to provoke a quicker immunological reaction.

Suppression of the immune system is often used to control autoimmune disorders or inflammation when this causes excessive tissue damage, and to prevent transplant rejection after an organ transplant. Commonly used immunosuppressants include glucocorticoids, azathioprine, methotrexate, ciclosporin, cyclophosphamide and mercaptopurine. In organ transplants, ciclosporin, tacrolimus, mycophenolic acid and various others are used to prevent organ rejection through selective T cell inhibition.

See also

Further reading

  • A standard textbook on the immune system is Immunobiology, by Charles Janeway, et al. The paperback of the sixth edition is ISBN 0815341016. NCBI makes the 5th edition available electronically at [1].

Template:Link FA Template:Link FA